Similarly, FFA2 is also thought to stimulate the release of PYY, so the absence of the receptor in the intestine might lead to decreased gut motility and reduced satiety, ultimately resulting in an increase in obesity. This evidence concerns the gene FFAR2 and obesity disorder.